Gene · 23186
Papers2,104
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,104
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Epigenomic and Metabolic Interplay in the Development of Metastatic Brain Tumors. | Oncol Res | 2026 | 41799524 | PubTator, text mining | PubMed |
| Pilot study: predicting the interplay between FOXO1 and its downstream long non-coding RNAs in HCC. | Front Oncol | 2026 | 41777650 | PubTator, text mining | PubMed |
| Mechanisms of HIV Latency in Hematopoietic Progenitors: GFI1 as a Key Regulator. | bioRxiv | 2026 | 41756862 | PubTator, text mining | PubMed |
| Stress-induced epigenome changes as a risk factor in the onset of mental disorders. | Front Psychiatry | 2026 | 41756569 | PubTator, text mining | PubMed |
| An Integrated Network Biology and Molecular Dynamics Approach Identifies CD44 as a Promising Therapeutic Target in Multiple Sclerosis. | Pharmaceuticals (Basel) | 2026 | 41754795 | PubTator, text mining | PubMed |
| Distinct Regulatory Genomic Architectures Distinguish Early-Onset from Late-Onset Alzheimer's Disease. | Genes (Basel) | 2026 | 41751570 | PubTator, text mining | PubMed |
| A toolkit for programmable transcriptional engineering across eukaryotic kingdoms. | bioRxiv | 2026 | 41726944 | PubTator, text mining | PubMed |
| System biology and network-based approach to identify the therapeutic signatures and potential inhibitors against polycystic lipomembranous osteodysplasia with Sclerosing Leukoencephalopathy. | PLoS One | 2026 | 41719345 | PubTator, text mining | PubMed |
| Molecular interplay of ASNS and the PI3K-AKT-mTOR pathway in CMV and HIV co-infections: Therapeutic implications. | PLoS One | 2026 | 41719286 | PubTator, text mining | PubMed |
| Genetic-Epigenetic Interplay in Epilepsy: Pathways, Biomarkers, and Epigenome-Targeted Therapies. | Epigenomes | 2026 | 41718408 | PubTator, text mining | PubMed |
| PROTACs for Collateral Degradation: Is It Time to Back Up the Bus? | ACS Med Chem Lett | 2026 | 41704369 | PubTator, text mining | PubMed |
| Antigen-specific TH17 cells offset the age-related decline in durable T cell immunity. | Sci Adv | 2026 | 41650263 | PubTator, text mining | PubMed |
| A DNABERT based deep learning framework for predicting transcription factor binding sites. | Sci Rep | 2026 | 41634097 | PubTator, text mining | PubMed |
| SUMOylation is destined for regulatory T cell-related immune dysregulation. | Cell Death Discov | 2026 | 41633969 | PubTator, text mining | PubMed |
| From Serendipity to Strategy: Rationalizing Molecular Glue Discovery and Proximity-Induced Pharmacology through Chemical Biology. | J Am Chem Soc | 2026 | 41622634 | PubTator, text mining | PubMed |
| CoREST complex inhibition alters RNA splicing to promote neoantigen expression and enhance tumor immunity. | JCI Insight | 2026 | 41364533 | PubTator, text mining | PubMed |
| Role of Galectin-1 in the Pathogenesis of Melanoma. | J Cancer Sci Clin Ther | 2025 | 41918780 | PubTator, text mining | PubMed |
| Versatile roles of inositol hexakisphosphate in the ubiquitin-proteasome system. | Essays Biochem | 2025 | 41700458 | PubTator, text mining | PubMed |
| Balancing Activation and Repression: CoREST-p300 Antagonism Controls Retinoic Acid-Driven Differentiation in AML. | bioRxiv | 2025 | 41279630 | PubTator, text mining | PubMed |
| The CoREST Complex Regulates Alternative Splicing by the Transcriptional Regulation of RNA Processing Genes in Melanoma Cells. | Cells | 2025 | 41227344 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23186/papers?page=2